HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Reiter Selected Research

Splenomegaly

12/2016Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Reiter Research Topics

Disease

11Neoplasms (Cancer)
01/2017 - 01/2000
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2016 - 01/2000
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2005 - 01/2000
4Leukemia
02/2016 - 03/2003
4Eosinophilia
11/2013 - 01/2006
4Residual Neoplasm
02/2009 - 01/2000
4Philadelphia Chromosome
07/2001 - 01/2000
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2016 - 06/2001
3Pdgfra-Associated Chronic Eosinophilic Leukemia
08/2015 - 01/2012
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2012 - 05/2001
3Lymphoma (Lymphomas)
07/2008 - 02/2000
3Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2003 - 01/2000
2Systemic Mastocytosis
12/2016 - 02/2016
2Disease Progression
02/2016 - 10/2014
2Hypereosinophilic Syndrome (Loeffler Endocarditis)
08/2015 - 01/2006
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2013 - 02/2010
2Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2008 - 12/2001
2Hematologic Neoplasms (Hematological Malignancy)
06/2007 - 08/2006
2Burkitt Lymphoma (Burkitt's Lymphoma)
03/2003 - 09/2000
2Second Primary Neoplasms (Neoplasms, Second)
11/2001 - 06/2001
1Primary Myelofibrosis (Myelosclerosis)
01/2017
1Neutropenia
01/2017
1Thrombocytopenia (Thrombopenia)
01/2017
1Splenomegaly
12/2016
1Mastocytosis
10/2014
1Blast Crisis (Blast Phase)
11/2013
1Breast Neoplasms (Breast Cancer)
01/2011
1Genetic Translocation (Chromosomal Translocation)
01/2011
1Multiple Sclerosis
01/2011
1Parkinson Disease (Parkinson's Disease)
05/2006
1Cough
01/2006
1Bronchitis
01/2006
1Chronic Cough
01/2006
1Asthma (Bronchial Asthma)
01/2006
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2005
1Tendon Entrapment (Stenosing Tenosynovitis)
07/2005
1Chromosome Aberrations (Chromosome Abnormalities)
06/2005
1Sepsis (Septicemia)
03/2004
1Panniculitis
09/2003
1Tumor Lysis Syndrome
03/2003
1Aneuploidy (Aneuploid)
07/2002
1Ewing Sarcoma (Sarcoma, Ewing)
11/2001

Drug/Important Bio-Agent (IBA)

7Imatinib Mesylate (Gleevec)FDA Link
11/2013 - 09/2003
6Interferon-alpha (Interferon Alfa)IBA
03/2006 - 01/2000
5Pharmaceutical PreparationsIBA
01/2017 - 07/2008
4Prednisone (Sone)FDA LinkGeneric
05/2013 - 06/2000
3Tyrosine Kinase InhibitorsIBA
03/2016 - 01/2006
3Methotrexate (Mexate)FDA LinkGeneric
05/2013 - 06/2001
3Daunorubicin (Cerubidine)FDA LinkGeneric
05/2013 - 05/2001
2Anaplastic Lymphoma KinaseIBA
10/2016 - 02/2013
2AntigensIBA
10/2016 - 02/2000
2Phosphotransferases (Kinase)IBA
08/2015 - 07/2008
2Factor V (Coagulation Factor V)IBA
05/2013 - 02/2010
2Sorafenib (BAY 43-9006)FDA Link
11/2012 - 01/2012
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2011 - 05/2001
2Proteins (Proteins, Gene)FDA Link
07/2008 - 12/2001
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2006 - 07/2002
2Etoposide (VP 16)FDA LinkGeneric
11/2001 - 06/2001
2Cytarabine (Cytosar-U)FDA LinkGeneric
06/2001 - 05/2001
1pomalidomideIBA
01/2017
1Alkaline PhosphataseIBA
12/2016
1Peptides (Polypeptides)IBA
10/2016
1HLA-A Antigens (HLA-A)IBA
10/2016
1midostaurinIBA
02/2016
1Immunoglobulin E (IgE)IBA
02/2016
1CGP 52421IBA
02/2016
1CGP 62221IBA
02/2016
1Tryptases (Tryptase)IBA
10/2014
1CytokinesIBA
06/2013
1Oncostatin MIBA
06/2013
1Rituximab (Mabthera)FDA Link
05/2013
1Monoclonal AntibodiesIBA
05/2013
1nilotinibFDA Link
01/2012
1Oncogene Proteins (Oncogene Protein)IBA
01/2011
1tyrosine receptor (receptor, tyrosine)IBA
07/2008
1Janus Kinase 2IBA
07/2008
1Interleukin-5 (Interleukin 5)IBA
12/2007
1Biological ProductsIBA
08/2006
1Dopamine Agents (Dopaminergic Agents)IBA
05/2006
1Proton Pump InhibitorsIBA
01/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2006
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2005
1Hemoglobins (Hemoglobin)IBA
06/2005
1Anti-Bacterial Agents (Antibiotics)IBA
03/2004
1Hydroxyurea (Hydrea)FDA LinkGeneric
08/2003
1InterferonsIBA
08/2003
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2003
1Urate Oxidase (Uricase)IBA
03/2003
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
07/2002
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2001
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
12/2001
1Topoisomerase InhibitorsIBA
11/2001
1Alkylating AgentsIBA
11/2001

Therapy/Procedure

18Therapeutics
01/2015 - 01/2000
6Radiotherapy
05/2013 - 01/2000
6Drug Therapy (Chemotherapy)
03/2004 - 01/2000
2Stem Cell Transplantation
03/2016 - 02/2000
2Hematopoietic Stem Cell Transplantation
03/2006 - 02/2000
1Fundoplication
01/2006
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2005